Last updated: Nov 21, 2026
Ulrich Mahlknecht, Hematologist
- Specialization: Hematologist
- 31 years of experience
- Speaks:English
- Online consultations: available
- Workplace: Germany, Dusseldorf, Düsseldorf Clinics Association
- Founder and Editor-in-Chief of Clinical Epigenetics (Springer).
Prof. Dr. med. Ulrich Mahlknecht, PhD, is a German hematologist and medical oncologist with over 30 years of experience in blood cancers and solid tumors. His focus includes AML, CLL, MDS, lymphomas, gastrointestinal oncology, and palliative care. He also provides second opinions for complex cases.
He served as Chief Physician of Hematology and Oncology in Solingen from 2012 to 2020. He held a W3 professorship and directed the Chair of Immunotherapy and Gene Therapy at Saarland University. He was a senior physician in Heidelberg and led the MDS Center of Excellence and the MDS/Acute Leukemia Task Force. He earned his Dr. med. in 1995 and a PhD from SUNY in 1998. He completed his Habilitation in 2004 and holds USMLE/ECFMG certification.
He has authored about 100 publications, including in The Lancet, Blood, and Leukemia. He has been a principal investigator or investigator in more than 20 leukemia and MDS trials. He founded the journal Clinical Epigenetics (Springer) and served as Editor-in-Chief. He received the Clinical Science Award in 2004 and led a DFG Emmy Noether group. He is board-certified in Internal Medicine, Hematology and Oncology, Gastroenterology, Palliative Medicine, and Nutritional Medicine. He is a member of DGHO, ESMO, ASH, AACR, and DKG. He offers online, written, and in-person consultations in Solingen. Languages: German, English, Italian, French.
Online consultation with Ulrich Mahlknecht
Patient reviews
Doctor's services
- Chemotherapy
- Lymphoma chemotherapy
- Leukemia chemotherapy
- Ultrasound
- CT (computer tomography)
- Biopsy
- Online Consultation with Oncologist
- Immunohistochemistry
- Tumor Marker Blood Test
How are we doing?
Qualifications
Prof. Dr. med. Ulrich Mahlknecht, PhD is a German hematologist and medical oncologist with more than 30 years of clinical and academic experience in the diagnosis and treatment of blood cancers and solid tumors.
Areas of expertise
- Acute and chronic leukemia (AML, CLL)
- Myelodysplastic syndromes (MDS)
- Lymphomas and other hematological malignancies
- Solid tumors, gastrointestinal oncology, palliative care
- Second opinions on complex cancer cases
Consultation formats for international patients
- Online video consultation
- Written second opinion based on medical records
- In-person consultation in Solingen, Germany
Professional experience
- 2012–2020: Chief Physician, Department of Internal Medicine, Hematology and Oncology, Solingen
- 2007–2011: Full Professor (W3) and Director, Chair of Immunotherapy and Gene Therapy, Saarland University; Head of the Competence Center for Molecular Medicine
- 2004–2007: Senior Physician, Department of Hematology and Oncology, Heidelberg University Hospital; Head of the MDS Center of Excellence and the Task Force for MDS and Acute Leukemia
- 1999–2003: Hematology and Oncology, Goethe University Frankfurt
- 1996–1998: Molecular medicine research, Picower Institute for Medical Research, New York, USA
Education
- Medical studies at the Universities of Bochum, Tübingen, Birmingham (UK) and Paris-Sud (France)
- Doctor of Medicine (Dr. med.), University of Tübingen, 1995
- PhD in Molecular Medicine, State University of New York, 1998
- Habilitation in Internal Medicine, Goethe University Frankfurt, 2004
- US medical licensing examinations passed (USMLE, ECFMG certificate)
Board certifications
Internal Medicine; Hematology and Medical Oncology; Gastroenterology; Palliative Medicine; Nutritional Medicine.
Research and achievements
- Around 100 scientific publications, including The Lancet, Blood and Leukemia
- Principal investigator or investigator in more than 20 clinical trials in leukemia and MDS
- Founder and Editor-in-Chief of the journal Clinical Epigenetics (Springer)
- Clinical Science Award of the German Society for Immunotherapy (2004)
- Emmy Noether research group of the German Research Foundation (DFG)
Memberships
German Society of Hematology and Oncology (DGHO), European Society for Medical Oncology (ESMO), American Society of Hematology (ASH), American Association for Cancer Research (AACR), German Cancer Society (DKG).
Languages: German, English, Italian, French.
You may also be interested
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with installment options.
Earn rewards for referring friends to Bookimed.